Annual EBITDA
$4.08B$195.00M+5.01%
Summary
- Current Value
- As of today, ZTS annual EBITDA is $4.08B, up +5.01% on
- Historical Performance
- ZTS annual EBITDA is up +20.37% over the past 3 years, up +50.70% over the past 5 years
- All-Time High Comparison
- ZTS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ZTS annual EBITDA is +20.37% above its 3-year low of $3.39B reached on an earlier date
- Sector Comparison
- ZTS annual EBITDA is higher than 97.17% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.08B | +5.0% | +20.4% | +50.7% | +726.7% | |
| Quarterly EBITDA | $1.03B | -10.6% | +11.2% | +22.3% | +294.2% | |
| TTM EBITDA | $4.03B | -1.4% | +14.1% | +27.6% | +518.3% | |
| Price | $80.79 | -31.0% | -53.8% | -64.3% | – | |
| PE Ratio | 13.72 | -31.0% | -61.4% | -74.8% | – | |
| Annual Revenue | $9.47B | +2.3% | +17.2% | +41.8% | +164.3% | |
| Annual EPS | $6.02 | +10.2% | +34.0% | +76.0% | +2637.5% | |
| $3.60B | +6.0% | +22.9% | +58.5% | +1064.1% | ||
| Annual Net Income | $2.67B | +7.1% | +26.6% | +63.4% | +2308.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.08B | at high | |
| 5Y | $4.08B | at high | |
| All | $4.08B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.39B | N/A | +20.4% |
| 5Y | $2.71B | N/A | +50.7% |
| All | $405.00M | +908.4% |
EBITDA History
FAQ
- What is the current annual EBITDA of ZTS?
- As of today, ZTS annual EBITDA is $4.08B
- What is 1-year change in ZTS annual EBITDA?
- ZTS annual EBITDA is up +5.01% year-over-year
- What is 3-year change in ZTS annual EBITDA?
- ZTS annual EBITDA is up +20.37% over the past 3 years
- How far is ZTS annual EBITDA from its all-time high?
- ZTS annual EBITDA is currently at its all-time high
- How does ZTS annual EBITDA rank versus sector peers?
- ZTS annual EBITDA is higher than 97.17% of companies in Healthcare sector
- When is ZTS next annual earnings release?
- The next annual earnings release for ZTS is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$1.03B$93.00M-8.32%
Summary
- Current Value
- As of today, ZTS quarterly EBITDA is $1.03B, down -8.32% on
- Historical Performance
- ZTS quarterly EBITDA is down -10.64% year-over-year, up +11.17% over the past 3 years
- All-Time High Comparison
- ZTS quarterly EBITDA is currently -10.64% below its historical high of $1.15B set on
- 3-Year Low Comparison
- ZTS quarterly EBITDA is +22.75% above its 3-year low of $835.00M reached on
- Sector Comparison
- ZTS quarterly EBITDA is higher than 96.54% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.03B | -8.3% | -10.6% | +11.2% | +22.3% | |
| Annual EBITDA | $4.08B | – | +5.0% | +20.4% | +50.7% | |
| TTM EBITDA | $4.03B | -2.9% | -1.4% | +14.1% | +27.6% | |
| Price | $80.79 | +5.4% | -31.0% | -53.8% | -64.3% | |
| PE Ratio | 13.72 | +8.8% | -31.0% | -61.4% | -74.8% | |
| Quarterly Revenue | $2.39B | -3.1% | -1.3% | +11.2% | +20.1% | |
| Quarterly EPS | $1.44 | -13.2% | -11.7% | +11.2% | +23.9% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Quarterly Net Income | $591.00M | -14.5% | -18.0% | -0.8% | +7.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.15B | N/A | -10.6% |
| 3Y | $1.15B | -10.6% | |
| 5Y | $1.15B | -10.6% | |
| All | $1.15B | -10.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $941.00M | +8.9% | |
| 3Y | $835.00M | +22.8% | |
| 5Y | $713.00M | +43.8% | |
| All | $191.00M | +436.6% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of ZTS?
- As of today, ZTS quarterly EBITDA is $1.03B
- What is ZTS quarterly EBITDA most recent change?
- ZTS quarterly EBITDA was down -8.32% on September 30, 2026
- What is 1-year change in ZTS quarterly EBITDA?
- ZTS quarterly EBITDA is down -10.64% year-over-year
- How far is ZTS quarterly EBITDA from its all-time high?
- ZTS quarterly EBITDA is currently -10.64% below its historical high of $1.15B set on September 30, 2025
- How does ZTS quarterly EBITDA rank versus sector peers?
- ZTS quarterly EBITDA is higher than 96.54% of companies in Healthcare sector
- When is ZTS next earnings release?
- The next earnings release for ZTS is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$4.03B$122.00M-2.94%
Summary
- Current Value
- As of today, ZTS TTM EBITDA is $4.03B, down -2.94% on
- Historical Performance
- ZTS TTM EBITDA is down -1.37% year-over-year, up +14.06% over the past 3 years
- All-Time High Comparison
- ZTS TTM EBITDA is currently -3.01% below its historical high of $4.16B set on
- 3-Year Low Comparison
- ZTS TTM EBITDA is +14.06% above its 3-year low of $3.53B reached on an earlier date
- Sector Comparison
- ZTS TTM EBITDA is higher than 96.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.03B | -2.9% | -1.4% | +14.1% | +27.6% | |
| Annual EBITDA | $4.08B | – | +5.0% | +20.4% | +50.7% | |
| Quarterly EBITDA | $1.03B | -8.3% | -10.6% | +11.2% | +22.3% | |
| Price | $80.79 | +5.4% | -31.0% | -53.8% | -64.3% | |
| PE Ratio | 13.72 | +8.8% | -31.0% | -61.4% | -74.8% | |
| TTM Revenue | $9.51B | -0.3% | +1.0% | +13.6% | +24.8% | |
| TTM EPS | $5.89 | -3.1% | -0.0% | +19.7% | +41.8% | |
| $2.65B | -26.1% | -24.6% | -13.2% | -2.7% | ||
| TTM Net Income | $2.49B | -5.0% | -5.5% | +9.2% | +25.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.16B | -3.0% | |
| 3Y | $4.16B | -3.0% | |
| 5Y | $4.16B | -3.0% | |
| All | $4.16B | -3.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.03B | at low | |
| 3Y | $3.53B | N/A | +14.1% |
| 5Y | $3.16B | N/A | +27.6% |
| All | $201.00M | +1905.5% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of ZTS?
- As of today, ZTS TTM EBITDA is $4.03B
- What is ZTS TTM EBITDA most recent change?
- ZTS TTM EBITDA was down -2.94% on September 30, 2026
- What is 1-year change in ZTS TTM EBITDA?
- ZTS TTM EBITDA is down -1.37% year-over-year
- How far is ZTS TTM EBITDA from its all-time high?
- ZTS TTM EBITDA is currently -3.01% below its historical high of $4.16B set on March 31, 2026
- How does ZTS TTM EBITDA rank versus sector peers?
- ZTS TTM EBITDA is higher than 96.44% of companies in Healthcare sector
- When is ZTS next earnings release?
- The next earnings release for ZTS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ZTS Official Website www.zoetis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1555280/000155528026000011/0001555280-26-000011-index.htm
- ZTS Profile on Yahoo Finance finance.yahoo.com/quote/ZTS
- ZTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zts
